Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
MedPage Today) — The FDA expanded the approval of dostarlimab (Jemperli) plus chemotherapy for primary advanced or recurrent endometrial cancer to include patients with mismatch repair proficient/microsatellite stable tumors. A survey study…
MedPage Today) — The FDA expanded the approval of dostarlimab (Jemperli) plus chemotherapy for primary advanced or recurrent endometrial cancer to include patients with mismatch repair proficient/microsatellite stable tumors.
A survey study…
Read More
About Author
